Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. PEGylated Proteins Market, by Region, 2019-2029 (USD Billion)
1.2.2. PEGylated Proteins Market, by Protein Type, 2019-2029 (USD Billion)
1.2.3. PEGylated Proteins Market, by Product & Services, 2019-2029 (USD Billion)
1.2.4. PEGylated Proteins Market, by Application, 2019-2029 (USD Billion)
1.2.5. PEGylated Proteins Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global PEGylated Proteins Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global PEGylated Proteins Market Dynamics
3.1. PEGylated Proteins Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising consumption of proteins-based drugs
3.1.1.2. Rising prevalence of chronic diseases
3.1.2. Market Challenges
3.1.2.1. High cost of the production process for PEGylation
3.1.2.2. Patent expiration for novel PEGylated biologics
3.1.3. Market Opportunities
3.1.3.1. Growing investment in the R&D of biologics
3.1.3.2. High presence of strong pipeline drugs
Chapter 4. Global PEGylated Proteins Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global PEGylated Proteins Market, by Protein Type
6.1. Market Snapshot
6.2. Global PEGylated Proteins Market by Protein Type, Performance - Potential Analysis
6.3. Global PEGylated Proteins Market Estimates & Forecasts by Protein Type 2019-2029 (USD Billion)
6.4. PEGylated Proteins Market, Sub Segment Analysis
6.4.1. Colony-stimulating factor
6.4.2. Interferons
6.4.3. Erythropoietin
6.4.4. Recombinant factor VII
6.4.5. Others
Chapter 7. Global PEGylated Proteins Market, by Product & Services
7.1. Market Snapshot
7.2. Global PEGylated Proteins Market by Product & Services, Performance - Potential Analysis
7.3. Global PEGylated Proteins Market Estimates & Forecasts by Product & Services 2019-2029 (USD Billion)
7.4. PEGylated Proteins Market, Sub Segment Analysis
7.4.1. Consumables
7.4.2. Services
Chapter 8. Global PEGylated Proteins Market, by Application
8.1. Market Snapshot
8.2. Global PEGylated Proteins Market by Application, Performance - Potential Analysis
8.3. Global PEGylated Proteins Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
8.4. PEGylated Proteins Market, Sub Segment Analysis
8.4.1. Cancer
8.4.2. Autoimmune diseases
8.4.3. Hepatitis
8.4.4. Multiple sclerosis
8.4.5. Hemophilia
8.4.6. Gastrointestinal disorders
8.4.7. Others
Chapter 9. Global PEGylated Proteins Market, by End-User
9.1. Market Snapshot
9.2. Global PEGylated Proteins Market by End-User, Performance - Potential Analysis
9.3. Global PEGylated Proteins Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
9.4. PEGylated Proteins Market, Sub Segment Analysis
9.4.1. Pharmaceutical & biotechnology companies
9.4.2. Contract research organizations
9.4.3. Academic & research institutes
Chapter 10. Global PEGylated Proteins Market, Regional Analysis
10.1. PEGylated Proteins Market, Regional Market Snapshot
10.2. North America PEGylated Proteins Market
10.2.1. U.S. PEGylated Proteins Market
10.2.1.1. Protein Type breakdown estimates & forecasts, 2019-2029
10.2.1.2. Product & Services breakdown estimates & forecasts, 2019-2029
10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
10.2.1.4. End-User breakdown estimates & forecasts, 2019-2029
10.2.2. Canada PEGylated Proteins Market
10.3. Europe PEGylated Proteins Market Snapshot
10.3.1. U.K. PEGylated Proteins Market
10.3.2. Germany PEGylated Proteins Market
10.3.3. France PEGylated Proteins Market
10.3.4. Spain PEGylated Proteins Market
10.3.5. Italy PEGylated Proteins Market
10.3.6. Rest of Europe PEGylated Proteins Market
10.4. Asia-Pacific PEGylated Proteins Market Snapshot
10.4.1. China PEGylated Proteins Market
10.4.2. India PEGylated Proteins Market
10.4.3. Japan PEGylated Proteins Market
10.4.4. Australia PEGylated Proteins Market
10.4.5. South Korea PEGylated Proteins Market
10.4.6. Rest of Asia Pacific PEGylated Proteins Market
10.5. Latin America PEGylated Proteins Market Snapshot
10.5.1. Brazil PEGylated Proteins Market
10.5.2. Mexico PEGylated Proteins Market
10.5.3. Rest of Latin America PEGylated Proteins Market
10.6. Rest of The World PEGylated Proteins Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific, Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Abcam plc.
11.2.3. Enzon Pharmaceuticals, Inc.
11.2.4. Merck KGaA
11.2.5. Celares GmbH
11.2.6. Profacgen
11.2.7. Creative PEGworks
11.2.8. NOF America Corp.
11.2.9. Aurigene Pharmaceutical Services Ltd.
11.2.10. Laysan Bio, Inc.
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption